Human Papilloma Virus Clinical Trial
Official title:
Promoting HPV Vaccination Through African American Beauty Salons: a Pilot Test of a Culturally-Competent Education and Empowerment Strategy
Verified date | October 2013 |
Source | MEE Productions, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The investigators propose a non-randomized pilot study to assess the feasibility and
effectiveness of using urban beauty salons as settings for culturally-competent health
education about HPV vaccination. The educational messages will engage individual women,
their peer group, their family members and community influencers in a way that is authentic
and share-able. Involving women in give-and-take discussions with people they trust and
respect—their hairdressers—will be essential to increasing the number of them who consider
the HPV vaccine for themselves and for those they care about. The investigators believe that
it is only after women who are opinion leaders among their peers begin positively supporting
HPV prevention that it will gain wider acceptance.
The investigators plan to recruit eight (8) predominantly African American beauty salons in
Philadelphia and train multiple stylists in each salon to act as in-salon educators and
facilitators for client recruitment to sexual health education sessions. These education
sessions will be run by trained health educators (also African American females) and take
place during "down times" in each of the salons, on a rotating basis.
- The investigators hypothesize the ability to successfully recruit eight (8) beauty
salons for participation
- The investigators hypothesize the ability to successfully train multiple stylists per
site to talk to their clients about HPV and its impact on women of color
- The investigators hypothesize that knowledge and awareness of HPV, as well as
intentions to vaccinate will significantly improve among women who attend a salon-based
health education session
Status | Completed |
Enrollment | 240 |
Est. completion date | July 2013 |
Est. primary completion date | July 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Mother of an 9-18 year old female - Female who is 18-26 years old Exclusion Criteria: - Not a mother of an 9-18 year old female - Not a female who is 18-26 years old |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Pre-selected beauty salons | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
MEE Productions, Inc. | Thomas Jefferson University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment of 8 beauty salons | To recruit 8 beauty salons from Philadelphia PA that would be willing to have their stylists trained to be part of the study, as well as have their salon serve as a host site for education sessions for their female customers. | 6 months | No |
Secondary | Intentions to Vaccinate Against HPV | To increase knowledge and awareness about HPV, as well as intentions to vaccinate among beauty salon clients. Intentions to vaccinate will be measured with a single item using the following wording "How likely are you (or your daughter) to start the HPV vaccine series in the next 6 months?". Response options range from "very likely" to "very unlikely" using a 5-point Likert scale. | 18 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05329961 -
Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old, An Exploratory Immunogenicity Study
|
Early Phase 1 | |
Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
Active, not recruiting |
NCT04199078 -
Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.
|
N/A | |
Recruiting |
NCT05566106 -
Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV
|
||
Not yet recruiting |
NCT06229353 -
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
|
||
Not yet recruiting |
NCT06436274 -
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
|
Phase 4 | |
Completed |
NCT01757392 -
Candin Safety & Efficacy Study for the Treatment of Warts
|
Phase 2 | |
Active, not recruiting |
NCT04716127 -
A Proximity-incentive Strategy for Cervical Cancer Screening
|
N/A | |
Recruiting |
NCT05210348 -
Clinical Evaluation of Detection of High Risk HPV in Urine
|
||
Recruiting |
NCT05835947 -
Anal Cancer Risk In Women
|
||
Not yet recruiting |
NCT03947775 -
HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL
|
Phase 2 | |
Terminated |
NCT03404310 -
Zinc Sulfate for Human Papillomavirus (HPV)
|
N/A | |
Recruiting |
NCT03302858 -
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand
|
Phase 2 | |
Completed |
NCT03082950 -
HPV Infections, Cancer of the Vulva and Therapeutical Success
|
||
Active, not recruiting |
NCT04950101 -
Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis
|
N/A | |
Recruiting |
NCT05146895 -
A Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts
|
N/A | |
Completed |
NCT04002154 -
Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV
|
N/A | |
Recruiting |
NCT04232917 -
Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
|
Phase 4 | |
Active, not recruiting |
NCT03729518 -
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
|
N/A | |
Recruiting |
NCT05640700 -
Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
|